Tuesday, September 26, 2023

Latest:

European Commission Approves mAbxience’s Bevacizumab For The Treatment Of Certain Types Of Cancer
Enerkon Solar International (ENKS) Names New Board and Scientific Committee Members and Announces New FARA Filing in Support of Commercial Aspirations
Delic’s Acquisition Target, Complex Biotech Discovery Ventures Ltd., Receives First Research Orders Through Online Payment Platform
FSD Pharma Inc. Management Wasting Company Money by Seeking to Further Delay Shareholder Meeting
PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

Biotech Market Reporter

Know First, Act First

Cannabis
General
Covid
Financing
Global
Trending

Featured

BIOTCHNO Featured

Enerkon Solar International (ENKS) Names New Board and Scientific Committee Members and Announces New FARA Filing in Support of Commercial Aspirations

April 1, 2021May 24, 2021 Raza

New York, New York–(Newsfile Corp. – April 1, 2021) – Enerkon Solar International (OTC Pink: ENKS) names new Board and

BIOTCHNO Featured

Xylonix Reveals New Drug Compound for Combating Cancer and Abnormal Macrophages

March 22, 2021June 2, 2021 Raza

Drug compound’s target therapeutic area include solid cancers and COVID-19 Canada NewsWire SINGAPORE , March 22, 2021 /CNW/ — Xylonix,

BIOTCHNO Featured

MindMed’s LSD Neutralizer Study Begins

February 17, 2021April 15, 2021 testdev

Canada NewsWire Potential Emergency Off-Switch for Psychedelic Assisted Therapies BASEL, Switzerland,Feb. 17, 2021/CNW/ — MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ),

BIOTCHNO Trending

SQI Diagnostics Announces New Corporate Website

February 18, 2021April 15, 2021 testdev

Canada NewsWire New Website Provides Essential Information on Company’s Strategic Initiative TORONTO, Feb. 18, 2021/CNW/ – SQI Diagnostics Inc. (the

BIOTCHNO Trending

Disclaimer
Privacy Policy

TD Media LLC dba Life Water Media
5826 New Territory Blvd. Unit #2144 Sugar Land, TX 77479